• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

靶向肠道菌群:多发性硬化症的新治疗机会。

Targeting gut microbiota: new therapeutic opportunities in multiple sclerosis.

机构信息

Laboratory of Genomics & Bioinformatics, Ludwik Hirszfeld Institute of Immunology & Experimental Therapy, Polish Academy of Sciences, Wroclaw, Poland.

Department of Neurology, Wroclaw Medical University, Wroclaw, Poland.

出版信息

Gut Microbes. 2023 Dec;15(2):2274126. doi: 10.1080/19490976.2023.2274126. Epub 2023 Nov 18.

DOI:10.1080/19490976.2023.2274126
PMID:37979154
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10730225/
Abstract

Multiple sclerosis (MS) causes long-lasting, multifocal damage to the central nervous system. The complex background of MS is associated with autoimmune inflammation and neurodegeneration processes, and is potentially affected by many contributing factors, including altered composition and function of the gut microbiota. In this review, current experimental and clinical evidence is presented for the characteristics of gut dysbiosis found in MS, as well as for its relevant links with the course of the disease and the dysregulated immune response and metabolic pathways involved in MS pathology. Furthermore, therapeutic implications of these investigations are discussed, with a range of pharmacological, dietary and other interventions targeted at the gut microbiome and thus intended to have beneficial effects on the course of MS.

摘要

多发性硬化症(MS)会导致中枢神经系统的持久、多灶性损伤。MS 的复杂背景与自身免疫炎症和神经退行性过程有关,并且可能受到许多影响因素的影响,包括肠道微生物群的组成和功能改变。在这篇综述中,提出了 MS 中发现的肠道菌群失调的特征的现有实验和临床证据,以及它与疾病进程以及涉及 MS 病理学的失调免疫反应和代谢途径的相关联系。此外,还讨论了这些研究的治疗意义,包括针对肠道微生物组的一系列药理学、饮食和其他干预措施,旨在对 MS 的病程产生有益影响。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a91/10730225/c8587bd4a663/KGMI_A_2274126_F0005_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a91/10730225/70bc9b1d2abc/KGMI_A_2274126_F0001_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a91/10730225/18a366981dc2/KGMI_A_2274126_F0002_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a91/10730225/cfee61ac50ef/KGMI_A_2274126_F0003_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a91/10730225/d814a641afa2/KGMI_A_2274126_F0004_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a91/10730225/c8587bd4a663/KGMI_A_2274126_F0005_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a91/10730225/70bc9b1d2abc/KGMI_A_2274126_F0001_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a91/10730225/18a366981dc2/KGMI_A_2274126_F0002_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a91/10730225/cfee61ac50ef/KGMI_A_2274126_F0003_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a91/10730225/d814a641afa2/KGMI_A_2274126_F0004_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a91/10730225/c8587bd4a663/KGMI_A_2274126_F0005_OC.jpg

相似文献

1
Targeting gut microbiota: new therapeutic opportunities in multiple sclerosis.靶向肠道菌群:多发性硬化症的新治疗机会。
Gut Microbes. 2023 Dec;15(2):2274126. doi: 10.1080/19490976.2023.2274126. Epub 2023 Nov 18.
2
Gut Microbiome in Alzheimer's Disease: from Mice to Humans.阿尔茨海默病中的肠道微生物组:从老鼠到人。
Curr Neuropharmacol. 2024;22(14):2314-2329. doi: 10.2174/1570159X22666240308090741.
3
Involvement of gut microbiota in multiple sclerosis-review of a new pathophysiological hypothesis and potential treatment target.肠道微生物群在多发性硬化症中的作用——新的病理生理学假说和潜在治疗靶点的综述。
Immunol Res. 2024 Aug;72(4):554-565. doi: 10.1007/s12026-024-09471-y. Epub 2024 Mar 6.
4
Feeding the gut microbiome: impact on multiple sclerosis.喂养肠道微生物组:对多发性硬化症的影响。
Front Immunol. 2023 May 25;14:1176016. doi: 10.3389/fimmu.2023.1176016. eCollection 2023.
5
Therapeutic Potential of the Gut Microbiota in the Prevention and Treatment of Sepsis.肠道微生物群在预防和治疗脓毒症中的治疗潜力。
Front Immunol. 2018 Sep 10;9:2042. doi: 10.3389/fimmu.2018.02042. eCollection 2018.
6
Modulating Gut Microbiota: An Emerging Approach in the Prevention and Treatment of Multiple Sclerosis.调节肠道微生物群:多发性硬化症预防和治疗的新方法。
Curr Neuropharmacol. 2021;19(11):1966-1983. doi: 10.2174/1570159X19666210217084827.
7
Dysbiosis in Multiple Sclerosis: Can Immunoglobulin Y Supplements Help?多发性硬化症中的生态失调:免疫球蛋白 Y 补充剂能有帮助吗?
J Gastrointestin Liver Dis. 2024 Mar 30;33(1):115-122. doi: 10.15403/jgld-5241.
8
Leveraging diet to engineer the gut microbiome.利用饮食来构建肠道微生物组。
Nat Rev Gastroenterol Hepatol. 2021 Dec;18(12):885-902. doi: 10.1038/s41575-021-00512-7. Epub 2021 Sep 27.
9
Multiple sclerosis and faecal microbiome transplantation: are you going to eat that?多发性硬化症与粪便微生物群移植:你打算吃那个吗?
Benef Microbes. 2019 Feb 8;10(1):27-32. doi: 10.3920/BM2018.0029. Epub 2018 Dec 10.
10
Therapeutic interventions for gut dysbiosis and related disorders in the elderly: antibiotics, probiotics or faecal microbiota transplantation?老年人群肠道菌群失调及相关疾病的治疗干预:抗生素、益生菌还是粪便微生物移植?
Benef Microbes. 2017 Apr 26;8(2):179-192. doi: 10.3920/BM2016.0115. Epub 2016 Dec 23.

引用本文的文献

1
Gut Microbiota-Derived Metabolites Orchestrate Metabolic Reprogramming in Diabetic Cardiomyopathy: Mechanisms and Therapeutic Frontiers.肠道微生物群衍生代谢物调控糖尿病心肌病中的代谢重编程:机制与治疗前沿
FASEB J. 2025 Sep 15;39(17):e71004. doi: 10.1096/fj.202501579RR.
2
Effect of Nematodes-Bacteria Complex Metabolites on Cancer and Tumor Progression.线虫-细菌复合代谢产物对癌症和肿瘤进展的影响
Biomolecules. 2025 Aug 14;15(8):1165. doi: 10.3390/biom15081165.
3
Gut microbiome dysregulation in noninfectious uveitis.非感染性葡萄膜炎中的肠道微生物群失调

本文引用的文献

1
Key role of the gut-microbiota-brain axis via the subdiaphragmatic vagus nerve in demyelination of the cuprizone-treated mouse brain.肠道微生物群-脑轴通过膈下迷走神经在杯状胶处理的小鼠脑脱髓鞘中的关键作用。
Neurobiol Dis. 2023 Jan;176:105951. doi: 10.1016/j.nbd.2022.105951. Epub 2022 Dec 6.
2
Lactobacillus reuteri tryptophan metabolism promotes host susceptibility to CNS autoimmunity.罗伊氏乳杆菌色氨酸代谢促进宿主易患中枢神经系统自身免疫。
Microbiome. 2022 Nov 23;10(1):198. doi: 10.1186/s40168-022-01408-7.
3
Gut microbiota composition as a candidate risk factor for dimethyl fumarate-induced lymphopenia in multiple sclerosis.
Front Immunol. 2025 Jul 29;16:1614304. doi: 10.3389/fimmu.2025.1614304. eCollection 2025.
4
Understanding the microbiome in autologous haemopoietic stem cell transplant for multiple sclerosis.了解多发性硬化自体造血干细胞移植中的微生物组。
Front Immunol. 2025 Jun 30;16:1590601. doi: 10.3389/fimmu.2025.1590601. eCollection 2025.
5
Exploring the role of gut microbiota in Parkinson's disease: insights from fecal microbiota transplantation.探索肠道微生物群在帕金森病中的作用:来自粪便微生物群移植的见解
Front Neurosci. 2025 Jun 13;19:1574512. doi: 10.3389/fnins.2025.1574512. eCollection 2025.
6
Breaking the Cycle: Can Vitamin D Bridge the Gap Between Gut Microbiota and Immune Dynamics in Multiple Sclerosis?打破循环:维生素D能否弥合多发性硬化症中肠道微生物群与免疫动力学之间的差距?
Int J Mol Sci. 2025 Jun 7;26(12):5464. doi: 10.3390/ijms26125464.
7
Gut Microbiota in a Viral Model of Multiple Sclerosis: Modulation and Pitfalls by Oral Antibiotic Treatment.多发性硬化症病毒模型中的肠道微生物群:口服抗生素治疗的调节作用与陷阱
Cells. 2025 Jun 9;14(12):871. doi: 10.3390/cells14120871.
8
Microbiota-Driven Mechanisms in Multiple Sclerosis: Pathogenesis, Therapeutic Strategies, and Biomarker Potential.多发性硬化症中微生物群驱动的机制:发病机制、治疗策略及生物标志物潜力
Biology (Basel). 2025 Apr 17;14(4):435. doi: 10.3390/biology14040435.
9
Gut Microbiota Dysbiosis: Pathogenesis, Diseases, Prevention, and Therapy.肠道微生物群失调:发病机制、疾病、预防与治疗
MedComm (2020). 2025 Apr 18;6(5):e70168. doi: 10.1002/mco2.70168. eCollection 2025 May.
10
Microbiota and Inflammatory Markers: A Review of Their Interplay, Clinical Implications, and Metabolic Disorders.微生物群与炎症标志物:它们的相互作用、临床意义及代谢紊乱综述
Int J Mol Sci. 2025 Feb 19;26(4):1773. doi: 10.3390/ijms26041773.
肠道微生物组成作为多发性硬化症中二甲基富马酸引起的淋巴细胞减少的候选风险因素。
Gut Microbes. 2022 Jan-Dec;14(1):2147055. doi: 10.1080/19490976.2022.2147055.
4
Mining the microbiota to identify gut commensals modulating neuroinflammation in a mouse model of multiple sclerosis.从微生物群中挖掘可调节多发性硬化症小鼠模型神经炎症的肠道共生菌。
Microbiome. 2022 Oct 17;10(1):174. doi: 10.1186/s40168-022-01364-2.
5
Gut microbiome of multiple sclerosis patients and paired household healthy controls reveal associations with disease risk and course.多发性硬化症患者和配对的家庭健康对照者的肠道微生物组揭示了与疾病风险和病程的关联。
Cell. 2022 Sep 15;185(19):3467-3486.e16. doi: 10.1016/j.cell.2022.08.021.
6
The gut microbiome molecular mimicry piece in the multiple sclerosis puzzle.肠道微生物组分子模拟在多发性硬化症谜题中的作用。
Front Immunol. 2022 Aug 15;13:972160. doi: 10.3389/fimmu.2022.972160. eCollection 2022.
7
Probiotics supplementation and brain-derived neurotrophic factor (BDNF): a systematic review and meta-analysis of randomized controlled trials.益生菌补充剂与脑源性神经营养因子(BDNF):随机对照试验的系统评价和荟萃分析。
Nutr Neurosci. 2023 Oct;26(10):942-952. doi: 10.1080/1028415X.2022.2110664. Epub 2022 Aug 22.
8
Gut Microbial Antigenic Mimicry in Autoimmunity.肠道微生物抗原模拟在自身免疫中的作用。
Front Immunol. 2022 Apr 27;13:873607. doi: 10.3389/fimmu.2022.873607. eCollection 2022.
9
Fecal microbiota transplantation is safe and tolerable in patients with multiple sclerosis: A pilot randomized controlled trial.粪便微生物群移植在多发性硬化症患者中是安全且可耐受的:一项试点随机对照试验。
Mult Scler J Exp Transl Clin. 2022 May 11;8(2):20552173221086662. doi: 10.1177/20552173221086662. eCollection 2022 Apr-Jun.
10
The Inflammatory Conspiracy in Multiple Sclerosis: A Crossroads of Clues and Insights through Mast Cells, Platelets, Inflammation, Gut Microbiota, Mood Disorders and Stem Cells.多发性硬化症中的炎症阴谋:通过肥大细胞、血小板、炎症、肠道微生物群、情绪障碍和干细胞揭示线索和深入见解的十字路口。
Int J Mol Sci. 2022 Mar 17;23(6):3253. doi: 10.3390/ijms23063253.